Is Caffeine safe in cosmetics?
Caffeine has a safety rating of "GOOD" in our database. EU status: permitted. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
Also known as: 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, 5-26-13-00558, Anhydrous caffeine, BRN 0017705, Cafamil (+14 more)
INCI: CAFFEINE
Caffeine (CAS 58-08-2) is a cosmetic active ingredient functioning as active / lipolytic / antioxidant. NOAEL 206.2 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: permitted, max 6% leave-on body, 1.5% eye lotions, 2% face powder. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety, pharmaceutical, and food safety data.
View industrial chemical safety profile for CAS 58-08-2 →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Caffeine.
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for Caffeine. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | 3 mg/kg bw/day | oral | rat | Neurotoxicity | COSMOS DB |
| NOAEL | 6 mg/kg bw/day | oral | rat | Developmental | COSMOS DB |
| NOAEL | 10 mg/kg bw/day | oral | rat | Special Toxicology Study | COSMOS DB |
| NOAEL | 12.5 mg/kg bw/day | oral | monkey | Multigeneration Reproductive | COSMOS DB |
| NOAEL | 13 mg/kg bw/day | oral | monkey | Reproductive | COSMOS DB |
| NOAEL | 15 mg/kg bw/day | oral | rat | Neurotoxicity | COSMOS DB |
| NOAEL | 20 mg/kg bw/day | oral | rat | Neurotoxicity | COSMOS DB |
| NOAEL | 22.5 mg/kg bw/day | oral | rat | Developmental | COSMOS DB |
| NOAEL | 24.7 mg/kg bw/day | oral | rat | Developmental | COSMOS DB |
| NOAEL | 25 mg/kg bw/day | oral | rat | Developmental | COSMOS DB |
Globally Harmonized System classification per ECHA C&L inventory and ILO/WHO International Chemical Safety Cards.
Pre-calculated NOAEL → SED → MoS audit trail for Caffeine across SCCS product categories, with measured dermal absorption where available.
Skin absorption and penetration characteristics of Caffeine, relevant to systemic exposure and MoS calculations.
Source: Skin Pharmacol Physiol 2007
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| LC50 | ~4940 mg/m3 | Rat | inhalation | - | ECHA |
| LD50 | >2000 mg/kg | Rat | dermal | acute | ECHA |
| LD50 | =367.7 mg/kg | Rat | oral | - | ECHA |
| LD50 | =185 mg/kg | Mouse | oral | - | ECHA |
| LD50 | >=200 mg/kg | Rat | oral | - | ECHA |
| LD50 | <=400 mg/kg | Rat | oral | - | ECHA |
| LEL | =220 mg/kg-day | Rat | oral | - | ECHA |
| LEL | =240 mg/kg-day | Rat | oral | - | ECHA |
| LEL | ~35 mg/kg-day | Mouse | oral | - | ECHA |
| LOEL | =20 mg/kg-day | Rat | oral | short-term | ECOTOX |
International Agency for Research on Cancer (WHO) monograph evaluation.
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Inserted via ATP: CLP00
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
Source: EPA Dryad Skin Absorption 2024
Source: Roberts Cheruvu Mendeley 2022
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured_in_vitro | 0.09-0.39 | In vitro; OECD TG 428 ring trial (GLP, 6 labs); Nitsche 2004 | Human split-thickness skin | Regul Toxicol Pharmacol 2022; Nitsche 2004 (2022) |
Reported concentration ranges per product category from SCCS/CIR/industry sources.
| Product Category | Typical Range | Max Reported | Source |
|---|---|---|---|
| Eye Cream | 0.5–3 | 5 | CIR Safety Assessment |
| Serum | 1–5 | 5 | CIR Safety Assessment |
10 property records from structured ingredient metadata.
Expert safety assessment and concern-level summary for Caffeine.
Public NOAEL study rows linked to Caffeine by CAS number or substance name.
| Absorption % | Method | Vehicle |
|---|---|---|
| 0.09-0.39 | In vitro; OECD TG 428 ring trial (GLP, 6 labs); Nitsche 2004 | Standard |
Same-CAS public records found in pharmaceutical and food safety data.
Same-CAS rows from the pharmaceutical spoke database.
Same-CAS food additive or FDA GRAS records from the core public database.
Flavoring ingredient in alcoholic beverages at levels of up to 200 parts per million
View full food safety profile →Caffeine has a safety rating of "GOOD" in our database. EU status: permitted. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
Caffeine EU regulatory status: permitted. Maximum allowed concentration: 6% leave-on body, 1.5% eye lotions, 2% face powder. This is based on EU Regulation 1223/2009 and its amendments.
Caffeine functions as: active / lipolytic / antioxidant. It is classified as a Active Ingredient in our database. CAS number: 58-08-2.
The NOAEL (No Observed Adverse Effect Level) for Caffeine is 3 mg/kg bw/day based on a Neurotoxicity study via oral route in rat. A total of 10 study endpoints are available. Source: COSMOS DB.
Caffeine also appears in industrial chemical safety, pharmaceutical, and food safety data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Caffeine compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Caffeine in your formulation.